research product . Other ORP type . 2012

Contribuição do consumo de carne reestruturada com Glucomanano e Glucomanano/Espirulina para o risco de doença cardiovascular

Matos, Cátia Sofia Fonseca;
Open Access Portuguese
  • Published: 01 Jan 2012
  • Country: Portugal
Abstract
Trabalho complementar (Trabalho de Investigação) realizado no âmbito da Unidade Curricular Estágio da Licenciatura em Ciências da Nutrição da Faculdade de Ciências da Nutrição e Alimentação da Universidade do Porto, sob orientação de Professor Doutor Francisco José Sánchez Muniz (Facultad de Farmácia de la Universidad Complutense de Madrid) Resumo da tese: A carne reestruturada com Glucomanano e Glucomanano/Espirulina é um potencial produto funcional. Neste trabalho estudaram-se os efeitos do seu consumo, em ratos Zucker Fa/Fa ao nível da colesterolemia, glucemia, peso final, alterações antioxidantes e perfil lipídico hepático. Seis grupos de seis ratos foram al...
Subjects
free text keywords: Ciências da Saúde, Ciências médicas e da saúde, Health sciences, Medical and Health sciences, Ciências médicas e da saúde, Medical and Health sciences
Related Organizations
48 references, page 1 of 4

C18:1n9/C18:0 sobe em HG vs G (p˂0.05), C22:6n3/C18:3n3 decresce (p˂0.01; p˂0.001; p˂0.001) 1. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. 2007.

2. Nus M, Sánchez-Muniz FJ. [Mª Pilar Vaquero] Importancia de la interacción dieta-genetica en la prevención cardiovascular. Genética, Nutrición y Enfermedad. Madrid : EDIMSA. Editores Médicos, S.A., 2008,127-144.

3. Instituto Nacional de Estatistica. Balança Alimentar Portuguesa 2003-2008. 2010.

4. Jiménez-Colmenero F, Sánchez-Muniz FJ, Olmedilla-Alonso B. Design and development of meat-based functional foods with walnut:Technological, nutritional and health impact. Food Chem. 2010; (123):959-967. [OpenAIRE]

5. Sánchez-Muniz FJ. Derivados cárnicos funcionales. Estrategias y perspectivas. Nuevos Alimentos. Madrid:1ªedición. Fundación Española de Nutrición (FEN). 2005; 43-54.

6. European Society of Cardiology, European Atherosclerosis Society. ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2011; (32):1769-1818.

7. Davidson MH, Hunninghake D, Maki KC, Kwiterovich PO, Kafonek S. Comparison of the effects of lean red meat vs lean white meat on serum lipid levels among free-living person with hipercholesterolemia. Arch Inter Med. 1999; (159):1331-1338. [OpenAIRE]

8. Schultz AM, González-Torres L, Olivero-David R, Bastida S, Benedi J, Sánchez-Muniz FJ. Wakame and Nori in restructured meats included in cholesterol-enriched diets affect the antioxidant enzyme gene expressions and activities in Wistar rats. Plant Foods Hum Nutr., 2010;(65):290-298.

9. Cheong S, Kim M, Sok D, Hwang S, Kim J, Kim H, Lee J, Kim Y, Kim M. Spirulina prevents atherosclerosis by reducing hypercholesterolemia in rabbits fed a high-cholesterol diet. J Nutr Sci Vitaminol., 2010;(56):34-40.

10. Ratcliffe I, Williams PA, Viebke C, Meadows J. Physicochemical Characterization of Konjac Glucomannan. Biomacromoles. 2005;(6):1977-1986.

11. Kraemer WJ, Vingren JL, Silvestre R, Spiering BA, Hatfield DL, Ho JY, Fragala MS, Maresh CM, Volek JS. Effect of adding exercise to a diet containing glucomannan. Metabol Clin Experim.2007;(56):1149-1158. [OpenAIRE]

12. Gallaher CM, Munion J, Hesslink R, Wise J, Gallaher DD. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr, 2000;(130): 2753-2759. [OpenAIRE]

13. Keithley J, Swanson B. Glucomannan and obesity: a critical review. Altern Therap in Health Med. 2005;(11):30-34.

14. Vasques CAR, Rossetto S, Halmenschlager G, Linden R, Heckler E, Fernandez MSP, Alonso JLL.Evaluation of the pharmacotherapeutic efficacy of Garcia cambogia plus Amorphophallus konjac for the treatment of obesity. Phytotheraphy Research, 2008;(22):1135-1140. [OpenAIRE]

15. Vuksan V, Jenkins DJA, Spadafora P, Sievenpiper JL, Owen R, Vidgen E, Brighenti F, Josse R, Leiter LA, Thompson CB. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. Diabetes Care, 1999; (22):913-919.

48 references, page 1 of 4
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue